1. Kirkham TC, Williams CM, Fezza F, Di Marzo V. Endocannabinoid levels in rat limbic forebrain and hypothalamus in relation to fasting, feeding and satiation: stimulation of eating by 2-arachidonoyl glycerol. Br J Pharmacol. 2002; 136: 550 Engeli S, Bohnke J, Feldpausch M, et al. Activation of the peripheral endocannabinoid system in human obesity. Diabetes. 2005; 54: 2838 Ameri A. The effects of cannabinoids on the brain. Prog Neurobiol. 1999; 58: 315348. Devane WA, Hanus L, Breuer A, et al. Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science. 1992; 258: 1946.
Hematological parameters are shown in Tables 2, 3 and 4. At baseline, mean Hb was 11.8 1.3 g dL. At 8 months, mean Hb increased to 12.4 0.93 g dL p 0.01 ; Table 2 ; . The overall prevalence of mild, moderate severe anemia was measured as the percentage of individuals responding to ironfortification during 8 m. Initially, 43.2% n 69 ; were evaluated as being anemic 11.8 g dL ; . the end of study, prevalence decreased to 21%. Before intervention began, 26.3% 42 ; of the children suffered from moderate anemia and 16.9% 27 ; suffered from severe anemia. At 8 m, 20.7% 32 ; and 3% 5 ; continued to suffer from less moderate and severe anemia, respectively Table 3 ; . The number of non-anemic had Table 2. Change in Variables before and 8 m Post-Intervention, for example, axid manufacturer.
Cheap Axidd online
But only a fraction of a percent of what is wrong with us is attributable to genetics and biochemistry!
Do not wash immediately after applying the medicine, for example, axid prescribing information.
BARNES, R. J., COMLINE, R. S., DOBSON, A. & DROST, C. J. 1983 ; . An implantable transit time ultrasonic blood flow meter. Journal of Physiology 345.P, 2-3P. BAUERFEIND, P., HOF, R., HOF, A., CUCALA, M., SIEGRIST, S., VON RITTER, C., FISCHER, J. A. & BLUM, A. L. 1989 ; . Effects of hCGRP I and II on gastric blood flow and acid secretion in anesthetized rabbits. American Journal of Physiology 256, G145-149. BRUGGEMAN, T. M., WOOD, J. G. & DAVENPORT, H. W. 1979 ; . Local control of blood flow in the dog's stomach: vasodilatation caused by acid back-diffusion following topical application of salicylic acid. Gastroenterology 77, 736-744. BURTON, R. G. & GOREwIT, R. C. 1984 ; . Ultrasonic flowmeter uses wide beam transit-time technique. Medical Electronics 15, 68-73. CELLER, B. G. & SCHRAMM, L. P. 1981 ; . Pre- and postganglionic sympathetic activity in splanchnic nerves of rats. American Journal of Physiology 241, R55-61. CLOZEL, M., BREU, V., GRAY, G. A., KALINA, B., LOFFLER, B.-M., BURRI, K., CASSAL, J.-M., HIRTH, G., MULLER, M., NEIDHART, W. & RAMUZ, H. 1994 ; . Pharmacological characterization of bosentan, a new potent orally active nonpeptide endothelin receptor antagonist. Journal of Pharmacology and Experimental Therapeutics 270, 228-235. FARA, J. W. 1984 ; . Postprandial mesenteric hyperemia. In Physiology of the Intestinal Circulation, ed. SHEPHERD, A. P. & GRANGER, D. N., pp. 99-106. Raven Press, New York!
PHYSICIAN MUST COMPLETE THIS SECTION AND INSTRUCT THE PATIENT AS TO WHAT MEDICATIONS SHOULD BE STOPPED PRIOR TO PROCEDURE 1. Esophageal Manometry - Drugs such as nitrates, calcium channel blockers, theophylline, metoclopramide ReglanTM ; or diazepam ValiumTM ; may affect esophageal motor activity. It is preferable to stop these drugs 24 hours prior to the test, if it is safe for your patient to do so. I have instructed my patient to stop the above drugs 24 hours prior to the test. Perform the test with the patient on the above drugs. Not applicable 2. Bernstein or Tensilon - Standard esophageal manometry with the addition of provocative testing may be performed. Provocative testing is used to help identify chest pain of esophageal origin and is done by administering Bernstein solution or injecting edrophonium TensilonTM ; . Drugs such as nitrates, calcium channel blockers, theophylline, metoclopramide ReglanTM ; or anxiolytics such as diazepam ValiumTM ; may affect esophageal motor activity. It is preferable to stop these drugs 24 hours prior to the test, if it is safe for your patient to do so. I have instructed my patient to stop the above drugs 24 hours prior to the test. Perform the test with the patient on the above drugs. Not applicable 3. Pharyngeal Manometry - Patients with oropharyngeal dysphagia in whom poor cricopharyngeal opening or relaxation is suspected from x-ray studies may benefit from pharyngeal manometry to document abnormalities. Drugs such as metoclopramide, domperidone, calcium channel blockers and nitrates may affect test results. I have instructed my patient to stop the above drugs 24 hours prior to the test. Do the test with the patient on the above drugs. Not applicable 4. 24-Hour pH Monitoring nasal catheter ; - In order to perform 24-Hour pH monitoring, esophageal manometry must first be done to locate the lower esophageal sphincter. Drugs such as proton pump inhibitors AciphexTM, NexiumTM, PrevacidTM, PrilosecTM, ProtonixTM ; or H2 blockers ZantacTM , PepcidTM, AxidTM , TagametTM ; affect test results. It is preferable that these drugs be withheld 7 days prior to the test. If you want to see results while on medical therapy, you may continue the medications. I have instructed my patient to hold the above drugs for 7 days prior to the test patient may take Rolaids, Tums, Mylanta ; . Do the test while on acid suppressive medication. Not applicable 5. 48-Hour Bravo pH capsule ; - In order to perform 48-Hour Bravo pH monitoring, location of the Z line must be known or esophageal manometry must first be done to locate the lower esophageal sphincter. Drugs such as proton pump inhibitors AciphexTM, NexiumTM, PrevacidTM, PrilosecTM, ProtonixTM ; or H2 blockers ZantacTM, PepcidTM, AxidTM, TagametTM ; affect test results. It is preferable that these drugs be withheld 7 days prior to the test. If you want to see results while on medical therapy, you may continue the medications. I have instructed my patient to hold the above drugs for 7 days prior to the test patient may take Rolaids, Tums, Mylanta ; . Do the test while on acid suppressive medication. Not applicable 6. 24-Hour pH Impedence nasal catheter ; - In order to perform 24-Hour pH monitoring, esophageal manometry must first be done to locate the lower esophageal sphincter. Drugs such as proton pump inhibitors AciphexTM, NexiumTM, PrevacidTM, PrilosecTM, ProtonixTM ; or H2 blockers ZantacTM, PepcidTM, AxidTM, TagametTM ; affect test results. It is preferable that these drugs be withheld 7 days prior to the test. If you want to see results while on medical therapy, you may continue the medications. I have instructed my patient to hold the above drugs for 7 days prior to the test patient may take Rolaids, Tums, Mylanta ; . Do the test while on acid suppressive medication. Not applicable 7. Electrogastrography EGG ; - Discontinue 48 hours prior to your test all drugs that can affect gastric motility such as prokinetics Reglan, Propulsid, domperidone, erythromycin, Zelnorm ; , narcotics, anticholinergics Bentyl, Levsin donnatal ; , antiemetics Compazine, Tigan, Zofran ; , NSAID's Motrin, Advil ; , antidepressants, oral contraceptives, tobacco and alcohol. 8. Anorectal Manometry and EMG - Performing anorectal manometry requires an alert and conscious patient. Local application of nitrates may affect pressure results. I have instructed my patient to stop the above drugs 24 hours prior to the test. Do the test with the patient on the above drugs. Not applicable , M.D. Signature , M.D. Date Printed Name FAX TO TMH CENTRALIZED SCHEDULING 713-790-4455 and
azelaic.
MAXIDONE * See hydrocodone-acetaminophen .11 MAXIPIME.13 MAXITROL * See MAXZIDE * See triamterene-hctz 75-50 mg tab .36 MAXZIDE-25 * See triamterene-hctz 37.5-25 mg tab .36 measles & rubella vaccine .58 measles, mumps & rubella virus vaccines .58 measles; mumps; rubella; varicella, live .59 measles virus vaccine.59 mebendazole .24 meclizine hcl .20 meclofenamate sodium .10 MECLOMEN * See meclofenamate sodium .10 MEDROL .52 MEDROL PAK ; * See methylprednisolone pak ; .51 MEDROL * See methylprednisolone 4 mg tab .51 MEDROL * See methylprednisolone 8 mg tab .51 medroxyprogesterone acetate .56 medroxyprogesterone acetate 150 mg ml inj.54 medroxyprogesterone acetate tab.56 mefloquine hcl .24 MEGACE * See megestrol acetate .56 MEGACE ES .56 megestrol acetate .56 megestrol acetate 625mg 5ml susp .56 MELLARIL * See thioridazine hcl.26 meloxicam.10 memantine hcl soln .18 memantine hcl tab .18 MENACTRA.58 MENEST .56 meningococcal a, c, y&w-135 ; polysaccharide conjugate vaccine .58 meningococcal vac a, c, y&w-135 .59 MENOMUNE .59 MENOSTAR .55 meperidine hcl tablets .11 meprobamate 200 mg.28 meprobamate 400 mg.28 MEPRON .24 mercaptopurine.23 meropenem .15 MERREM .15 MERUVAX II .59 mesalamine .60, 61 mesalamine enema .60 mesna tab .23 MESNEX .23 MESTINON .22 MESTINON * See pyridostigmine bromide 60 mg tab .22 METADATE ER * See methylin er .39 METADATE ER * See methylphenidate hcl cr .39 METAGLIP * See glipizide-metformin.28 metaxalone .68 metformin hcl .28 metformin hcl er .28 metformin hcl soln.28 metformin hydrochloride .29 METHADONE HCL.12 methadone hcl .11.
2-3 May Sydney Convention and Exhibition Centre, Darling Harbour, Sydney Communicable Diseases Control Conference The Communicable Diseases Network Australia CDNA ; and the Public Health Laboratory Network PHLN ; will hold a 2 day Communicable Diseases Control Conference on 2-3 May 2005 in Sydney. CDNA is the peak national body charged with managing public health aspects of communicable diseases in Australia. It is composed of representatives of health authorities in all States and Territories, the Australian Government and other experts in communicable diseases. PHLN, a sub-committee of CDNA, provides strategic advice and expertise to enhance the national capacity for the detection and control of agents and vectors of communicable diseases in Australia. Further information Communicable Diseases Control Conference Management Consec Conference Management PO Box 3127, BMDC, ACT 2617 Tel: 02 ; 6251 0675 Fax: 02 ; 6251 0672 E-mail: diseases05 consec .au 19-21 May Carrington Hotel, Katoomba, NSW Viruses in May A 3 day meeting, focusing on clinical and virological issues relating to diagnosis and therapy of human viral infection. Topics include introductory clinical and diagnostic virology, molecular viral diagnostics, viral infectious diseases in pregnancy and childhood and viral therapeutics. Specific seminars will include HSV HIV rubella, emerging infectious diseases, VZV EBV and CMV , . Contact: Louisa Jones E-mail: JonesL sesahs.nsw.gov.au and azithromycin, for example, axid fda.
Each section contains a comprehensive facilitator's guide. Developed in consultation with young people, this lively and interactive resource provides them with the information and the vital skills to deal with the difficult situations they face. Readership Personal, social and health education teachers.
Bacitracin zinc and hydrocortisone acetate and neomycin sulfate and polymyxin b sulfate BLEPHAMIDE BLEPHAMIDE LIQUIFILM BLEPHAMIDE S.O.P. dexamethasone and neomycin sulfate and polymyxin b sulfate dexamethasone sodium phosphate FLAREX fluorometholone flurbiprofen sodium FML FORTE FML S.O.P. FML-S LIQUIFILM hydrocortisone and neomycin sulfate and polymyxin b sulfate LOTEMAX MAXIDEX POLY-PRED PRED-G PRED-G S.O.P. prednisolone acetate prednisolone sodium phosphate prednisolone sodium phosphate prednisolone sodium phosphate and sulfacetamide sodium TOBRADEX VEXOL VOLTAREN and azulfidine.
Axid prices
GROUP COUNSELING Group Facilitation Skills for Counselors: 6hrs, 12hrs ; This course uses a variety of methods, including skills practice, to present essential elements of effective group facilitation. At the end of this course, counselors will have increased knowledge of group dynamics and their role as a group facilitator. Class size: limited to 30. Advanced Group Facilitation Skills for Counselors: 6, 12hrs ; This advanced training is designed to provide participants with the opportunity to apply their knowledge of group dynamics and theory to simulated group experiences. Feedback will be provided on demonstrated group skills and alternative approaches interventions will be recommended in a format that combines both experiential and presentation style exercises. Class size: limited to 30. Co-Facilitating Skills: 3hrs ; Today many organizations use two facilitators to run groups instead of one. There are both strengths and challenges unique to the co-facilitating relationship. This course will focus on providing the skills needed to establish an effective working relationship between co-facilitators. Identifying personal styles, communication problems, responsibilities and group format will all be discussed. Class size: limited to 30. Group Work with Adolescents: 6hrs ; This workshop is designed to provide participants with an overview of issues that surface when working with adolescents in a group setting. Participants will learn effective facilitation strategies and will have the opportunity to implement them in a combination of presentation and experiential style activities. Participants will be expected to have some previous background in adolescent development and basic group dynamics. Class size: limited to 30. Abuse Survivors: A Group Model: 3hrs ; This course will provide prevalence data concerning physical sexual abuse survivors in alcohol and substance abuse treatment programs. Adult behavioral indicators i.e. PTSD ; , effects on the family, & treatment considerations will be discussed. A sexual survivor group model will also be examined. Class size: unlimited.
If your sleep medication leaves you with daytime drowsiness or slowed reflexes as you start your day, call your doctor and
bactrim.
Axid is taken once or twice a day, with the usual dose being 150 to 300 mg.
Table 19.7: Oxygen and growth of moulds Moulds are aerobic Many Mucorales can produce fermentation. Increasing CO2 reduces growth of many moulds. At the same time reducing oxygen stops completely growth of molds on fruits. They grow however also as microaerobic and
bromocriptine.
IV. FINAL CONCLUSIONS 4.1 Difficulties Low level of spontaneous response from member organizations to emailed questionnaires. Evident difficulties related to access to, knowledge of and familiarity with new communication technologies. Lack of experience in the application of online methodologies to establish communication among member organizations. The first questionnaire sent took a broad perspective of reproductive health supplies and proposed a general approach to the theme, which likely caused confusion among the organizations regarding the objective of the consultation. Institutional weakness of women's organizations of the region. This is manifested in the lack of staff available to participate in activities that were novel or not included in their work plans. Some organizations have no computers, or very few, and those that exist are in high demand for conducting the business of the organization. Few staff members are trained to handle information technologies. This institutional weakness was also reflected in the organizations' high mobility; many of them change addresses regularly, which is a barrier to maintaining contact. Pressure from political, social and religious interest that criticize the organizations' work in women's sexual and reproductive health force the organizations to maintain a low profile on this issue, or simply to abandon all efforts, due to fear of reprisals that will hinder their work in other areas and could even threaten their legal status. The cuts and lack of funding for reproductive health and rights issues is having a direct impact on the work and projects that used to be done or will like to develop, many women's organizations. 4.2 Achievements Despite the difficulties described above, and the ad hoc measures that were needed to fulfill the project objective, we were able to establish a baseline on the level of involvement and interest among LACWHN member organizations in the area of reproductive health supplies, using the sampling method to analyze the situation and draw conclusions, for instance, axud pro.
Of modulation of another enzyme or drug transporter. However, differences in the composition of the active constituents of the garlic supplements used could also explain variation in the clinical results. Therefore, patients are advised to use caution when combining garlic supplements with saquinavir, but also with anticancer drugs metabolized by CYP3A4 and transported by Pgp Table 1, Table 2 ; [81]. Citrus aurantium, Panax ginseng, Echinacea purpurea, milk thistle, and saw palmetto extracts taken by healthy volunteers all had no effect on the activity of CYP3A4, CYP1A2, CYP2E1, and CYP3A4 measured using model substrates [77]. Milk thistle also did not influence the PK of the protease inhibitor indinavir in two independent studies [82, 83]. However, a recent study [84] showed that 8 days of echinacea treatment in volunteers resulted in a 34% greater systemic clearance of midazolam and a significantly lower AUC. In contrast, the oral bioavailability of midazolam after echinacea intake was significantly greater, indicating that there is a difference in the effect between hepatic and intestinal metabolism or drug transport. These data indicate that interactions of echinacea with anticancer drugs that are substrates of CYP3A4 is likely Table 1 and
cabergoline.
17th Annual Conference of the Australasian Society for HIV Medicine SYMPOSIUM INTERNATIONAL TESTING TESTING IS THIS THING WORKING? 11.00 12.15 pm, because adid and infants.
However, there is no specific information comparinguse of this medicine in children with use in other age groups and
cafergot.
Many new generic medications have become available over the last few months. The generic equivalent of Augmentin, Amoxicillin Clavulanate is now marketed in the following strengths: 500mg & 875mg oral tablets, 200mg & 400mg oral suspension & chewable tablets. Other commonly prescribed medications include: Glucophage Metformin ; , Ceftin Cefuroxime ; Axi Nizatidine ; , Prinivil and Zestril Lisinopril ; , Prinzide & Zestoretic Lisinopril and Hydro-chlorothiazide ; , Cytotec Misoprostol ; , Zanaflex Tizanidine ; , and Demadex Torsemide ; . Generic medications are generally priced ten to fifty percent below the price of brand name products.
Flected in premium prices; and If the conversion proposal is approved, establishing an adequately sized and governed public health foundation to assure that both public health and medical care purposes will be served to a degree that is fair, given the considerable economic benefit Premera has enjoyed as a nonprofit organization. WSPHA representatives have reviewed material prepared by Premera describing their proposed conversion. As of this date, the material contains insufficient detail to make a judgment about the conversion's impact on the public health of our state's residents. OIC has requested additional details about Premera's proposed governance, policy direction, priorities and the size, form and purposes of the proposed health foundation, all important in considering the effects of the conversion. Information from other states where conversions have been approved, while not conclusive as to harm or benefit, does seem to show that in at least some rural areas, payments to providers may have gone down even as premium costs increased. The OIC assures that proposers of conversions must thoroughly investigate and make public information on how the conversion will affect patient care, as well as its impact on the health insurance-buying public. Given WSPHA's long history of support for broadening access to health care to include everyone in Washington state, it looks forward to Premera providing these important details to be assured that the public's health will not be harmed by this proposal. WSPHA members wanting more information should visit OIC's website where they can provide written comments and feedback as well. The Board intends to continue conversations with Premera and others as the process moves forward, trying to come to a better understanding of the public health impacts of conversion and mulling whether to request assurances related to the concerns above. Please communicate your questions and concerns to us and calan.
Reflux GERD ; Famotidine Generic Pepcid ; $$ Nizatidine Generic Acid ; $$ Ranitidine $ Rabeprazole D.R. Gen. Aciphex ; $$$ Pantoprazole D.R. Gen Protonix ; $$$ Esomeprazole D.R. Gen. Nexium ; $$$$ Omeprazole D.R. Prilosec OTC ; $$ Lansoprazole D.R. Generic Prevacid ; $$$ Secretions Excessive ; Atropine Inj. or SL 0.4mg ml Transderm Scope Patches.
Streeper-l archives archiver streeper 2002-03 1016998091 from: joan higgins subject: axld date: sun, 24 mar 2002 : 11 -0500 in thinking about how axid is pronounced it could be spelled actsed and capoten and axid.
SETSYS DSBACKUP. DEMOUNTDELAY MAXIDLETASKS 2 ; MINUTES 60 ; DEFINE SWITCHTAPES DSBACKUP TIME 1730.
Table 15.10.2X Number % ; of Patients with Emergent Adverse Experiences Leading to Withdrawal By Age Category Male Specific ; . Phase II Randomized Treatment. Intention to Treat Population . 000587 Table 15.10.3 Number % ; of Patients with Emergent Adverse Experiences Leading to Withdrawal Male Specific ; . Taper Phase. Intention to Treat Population . 000589 Table 15.10.3X Number % ; of Patients with Emergent Adverse Experiences Leading to Withdrawal By Age Category Male Specific ; . Taper Phase. Intention to Treat Population . 000590 Table 15.11.1 Number % ; of Patients with Emergent Adverse Experiences Leading to Withdrawal Female Specific ; . Phase I Open-Label Treatment. Intention to Treat Population 000592 Table 15.11.1X Number % ; of Patients with Emergent Adverse Experiences Leading to Withdrawal By Age Category Female Specific ; . Phase I Open-Label Treatment. Intention to Treat Population . 000593 Table 15.11.2 Number % ; of Patients with Emergent Adverse Experiences Leading to Withdrawal Female Specific ; . Phase II Randomized Treatment. Intention to Treat Population . 000595 Table 15.11.2X Number % ; of Patients with Emergent Adverse Experiences Leading to Withdrawal By Age Category Female Specific ; . Phase II Randomized Treatment. Intention to Treat Population . 000596 Table 15.11.3 Number % ; of Patients with Emergent Adverse Experiences Leading to Withdrawal Female Specific ; . Taper Phase. Intention to Treat Population . 000598 Table 15.11.3X Number % ; of Patients with Emergent Adverse Experiences Leading to Withdrawal By Age Category Female Specific ; . Taper Phase. Intention to Treat Population . 000599 Table 15.12.1 Number % ; of Patients with Emergent Adverse Experiences Leading to Withdrawal Non-gender Specific ; . Phase I Open-Label Treatment. Intention to Treat Population 000601 Table 15.12.1X Number % ; of Patients with Emergent Adverse Experiences Leading to Withdrawal By Age Category Non-gender Specific ; . Phase I Open-Label Treatment. Intention to Treat Population . 000603 Table 15.12.2 Number % ; of Patients with Emergent Adverse Experiences Leading to Withdrawal non-gender Specific ; . Phase II Randomized Treatment. Intention to Treat Population . 000605 Table 15.12.2X Number % ; of Patients with Emergent Adverse Experiences Leading to Withdrawal By Age Category non-gender Specific ; . Phase II Randomized Treatment. Intention to Treat Population . 000606 and carbidopa.
1 vegetarian Vcaps capsule contains: Petasites Hybridus * Root Extract Supplying Sesquiterpenes 15.25% Petasin, Petasol, Neo Petasol, Iso-Petasol ; 75 mg, Feverfew 75 mg, Riboflavin 25 mg, * Pyrrolizidine alkaloid free. Suggested Usage: As a dietary supplement for adults take one 1 ; vegetarian Vcaps capsule, twice a day with meals or as directed by a healthcare practitioner.
Axid oral
FOLLOW-UP: * * * Provide adequate supply of progestogen-only pills. When problems arise or at least at 3 monthly visit. Provide condoms as a backup method ; 51.
Axid prescription online depends on axid withdrawal symptom.
This portion of the emedtv archives explains how afeditab cr works to control blood pressure and describes possible off-label uses of the drug such as treating preterm labor, because axid infant reflux.
Mebeverine HCl Cap 200mg M R Colofac Liq 50mg 5ml S F Colofac Tab 135mg Colofac MR Cap 200mg Peppermint Oil Cap E C 0.2ml Peppermint Oil Cap E C 0.2ml M R Colpermin Cap E C 0.2ml M R Mintec Cap E C 0.2ml Ispag Mebeverine Gran Eff 3.5g 135mg S F Fybogel Mebeverine Eff Gran Sach S F Propantheline Brom Tab 15mg Pro-Banthine Tab 15mg Cimetidine Tab 200mg Cimetidine Tab 400mg Cimetidine Tab 800mg Cimetidine Oral Soln 200mg 5ml Cimetidine Oral Susp 200mg 5ml S F Cimetidine Oral Soln 200mg 5ml S F Tagamet Tab 200mg Tagamet Tab 400mg Tagamet Tab 800mg Peptimax 400 Tab 400mg Famotidine Tab 20mg Famotidine Tab 40mg Famotidine Tab 10mg Pepcid Tab 20mg Pepcid Tab 40mg Nizatidine Cap 150mg Nizatidine Cap 300mg Ax8d Cap 150mg Xaid Cap 300mg Ranitidine Bism Cit Tab 400mg Ranitidine HCl Tab 150mg Ranitidine HCl Tab 300mg Ranitidine HCl Oral Soln 75mg 5ml S F Ranitidine HCl Tab Eff 150mg and azelaic.
You can shop with confidence when buying axid from north drugstore.
Where to buy Axid
Rampage had even the bloated pharma front men crying foul, the more insidious issues--an anachronistic treatment paradigm, a research and regulatory establishment high-jacked by industry-- go entirely unaddressed. It is with.